Our results from three different prostate cancer cell lines showed that PERK and IRE1α were phosphorylated at their activating domain (PERK/T980 and IRE1α/S724) as early as 2 h after Alternol treatment (Figures 3A–C). The gene discussed is EIF2AK3; the disease is prostate carcinoma.